Ask AI
Public Law114th CongressHealth
S. 139Became Law

Ensuring Access to Clinical Trials Act of 2015

This bill became law

Filed
Comm.
Floor
Both
Law

What it doesSummary public law (Oct 7, 2015)

This measure has not been amended since it was introduced. The expanded summary of the Senate-passed version is repeated here.)

Ensuring Access to Clinical Trials Act of 2015

(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.

What just happenedOct 7, 2015

Became Public Law No: 114-63.

Who’s behind it

Sen. Wyden, Ron [D-OR](D-OR)Sponsor
15 cosponsors10 D5 R
Read on Congress.gov
15cosponsors3committees25actions1related bills3subjects
  1. Oct 7, 2015President

    Became Public Law No: 114-63.

  2. Oct 7, 2015BecameLaw36000

    Became Public Law No: 114-63.

  3. Oct 7, 2015President

    Signed by President.

  4. Oct 7, 2015BecameLaw36000

    Signed by President.

  5. Sep 30, 2015Floor

    Presented to President.

  6. Sep 30, 2015President28000

    Presented to President.

  7. Sep 28, 2015FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  8. Sep 28, 2015FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6276)

  9. Sep 28, 2015Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H6276)

  10. Sep 28, 2015FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on S. 139.

  11. Sep 28, 2015FloorH30000

    Considered under suspension of the rules. (consideration: CR H6276-6279)

  12. Sep 28, 2015FloorH30300

    Mr. Ryan (WI) moved to suspend the rules and pass the bill.

  13. Jul 24, 2015Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  14. Jul 21, 2015Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  15. Jul 20, 2015IntroReferralH11100

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  16. Jul 20, 2015IntroReferralH11100

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Ways and Means Committee
  17. Jul 20, 2015IntroReferralH11100-A

    Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  18. Jul 20, 2015FloorH14000

    Received in the House.

  19. Jul 17, 2015Floor

    Message on Senate action sent to the House.

  20. Jul 16, 2015Floor

    Passed Senate without amendment by Unanimous Consent. (consideration: CR S5175; text as passed Senate: CR S5175)

  21. Jul 16, 2015Floor17000

    Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S5175; text as passed Senate: CR S5175)

  22. Jul 16, 2015Discharge

    Senate Committee on Finance discharged by Unanimous Consent.

    Finance Committee
  23. Jul 16, 2015Committee14500

    Senate Committee on Finance discharged by Unanimous Consent.

    Finance Committee
  24. Jan 8, 2015IntroReferral

    Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S105; text of measure as introduced: CR S105)

    Finance Committee
  25. Jan 8, 2015IntroReferral10000

    Introduced in Senate

Public LawOct 7, 201549

This measure has not been amended since it was introduced. The expanded summary of the Senate-passed version is repeated here.)

Ensuring Access to Clinical Trials Act of 2015

(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.

Passed House without amendmentSep 28, 201581

(This measure has not been amended since it was introduced. The expanded summary of the Senate-passed version is repeated here.)

Ensuring Access to Clinical Trials Act of 2015

(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.

Passed Senate without amendmentJul 16, 201582

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Ensuring Access to Clinical Trials Act of 2015

(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.

Introduced in SenateJan 8, 2015

Ensuring Access to Clinical Trials Act of 2015

This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.

Ensuring Access to Clinical Trials Act of 2015 — Informed